Abstract:STUDY QUESTION: Does P2X ligand-gated ion channel 3 (P2X3) play a role in endometriosis pain? SUMMARY ANSWER: Upregulation of P2X3 in dorsal root ganglia (DRG) tissues via the activating transcription factor 3 (ATF3)/activator protein (AP)-1 pathway contributed to endometriosis-associated hyperalgesia, which could be attenuated by the chitosan oligosaccharide stearic acid (CSOSA)/liposomes (LPs)/SP600125 delivery system. WHAT IS KNOWN ALREADY: Infiltrating nerve fibers and elevated nociceptors in endometriotic lesions are associated with endometriosis pain. P2X3 has been demonstrated to play an important role in neuropathic pain. STUDY DESIGN, SIZE, DURATION: A rat model of endometriosis was used to investigate the signaling pathways involved in P2X3-induced pain. PARTICIPANTS/MATERIALS, SETTING, METHODS: Degrees of hyperalgesia, endogenous adenosine 5'-triphosphate (ATP) contents and P2X3 expression levels in endometriotic lesions and DRG tissues were detected in a rat model of endometriosis. The expression levels of ATF3 and P2X3 were measured using qRT-PCR, western blot analysis and immunofluorescence analysis after adenosine 5'-diphosphate (ADP) exposure in DRG cells. Plasmids encoding ATF3 and its siRNA were used to investigate the role of ATF3 on ADP-induced P2X3 upregulation. The activity of ATF binding to the P2X3 promoter was evaluated by using chromatin immunoprecipitation (CHIP) and luciferase assays. SP600125, an inhibitor of c-JUN N-terminal kinase, was wrapped in CSOSA/LPs delivery system and its inhibitory effects on ADP-induced upregulation of P2X3 in DRG cells and endometriosis-induced hyperalgesia in rats were tested. MAIN RESULTS AND THE ROLE OF CHANCE: The concentrations of endogenous ATP and expression levels of P2X3 were significantly increased in both endometriotic lesions and DRG tissues in endometriosis rat models and were found to be positively correlated with the severity of hyperalgesia. In DRG cells, P2X3 expression levels were elevated by ADP stimulation, but dramatically inhibited by blocking ATF3 with its siRNA and SP600125. CHIP and luciferase assay showed that ADP increased the binding of ATF3 to the P2X3 promoter, resulting in an increase in P2X3 expression levels. In the CSOSA/LPs/SP600125 delivery system, the drug could be effectively concentrated in endometriotic lesions, and it could alleviate endometriosis-induced hyperalgesia, reduce the size of endometriotic lesions and attenuate upregulated P2X3 expression levels in endometriosis rat models. LARGE SCALE DATA: N/A LIMITATIONS, REASONS FOR CAUTION: Changes in the sensitivity and function of P2X3 caused by endometriosis need to be further investigated. WIDER IMPLICATIONS OF THE FINDINGS: This study indicates that ATP and the P2X3 receptor are involved in endometriosis pain, thus providing a novel therapeutic approach for the treatment of endometriosis pain by targeting the P2X3 receptor.

Relationship Between the Change of ATP Level Controlled by Ectonucleotidases and Endometriosis-Associated Infertility and Pain

P2X3 Receptor Involvement in Endometriosis Pain Via ERK Signaling Pathway.

Extracellular ATP (eatp) Inhibits the Progression of Endometriosis and Enhances the Immune Function of Macrophages.

Progress in Study of Nerve Growth Factor and Its Receptors on Mechanism of Endometriosis Pain

Estrogen is an Important Mediator of Mast Cell Activation in Ovarian Endometriomas

Activation of ATF3/AP-1 Signaling Pathway is Required for P2X3-induced Endometriosis Pain.

[Research Progress in the Role of Mitochondrial Dysfunction in Endometriosis-Associated Infertility]

Exosomes from the Uterine Cavity Mediate Immune Dysregulation via Inhibiting the JNK Signal Pathway in Endometriosis

The Effect of Peritoneal Fluid from Patients with Endometriosis on Mitochondrial Function and Development of Early Mouse Embryos

Prolonged Gonadotropin-Releasing Hormone Agonist Therapy Reduced Expression of Nitric Oxide Synthase in the Endometrium of Women with Endometriosis and Infertility

[Expression and Significance of ET-1 and Its Receptors in Endometriosis].

The Expression and Functionality of Transient Receptor Potential Vanilloid 1 in Ovarian Endometriomas

Adenosine Triphosphate Regresses Endometrial Explants in a Rat Model of Endometriosis

Identification and Validation of the Signatures of Infiltrating Immune Cells in the Eutopic Endometrium Endometria of Women With Endometriosis

Nerve fibers and endometriotic lesions: partners in crime in inflicting pains in women with endometriosis

The expression of nerve growth factor and its significance in eutopic endometrium of patients with endometriosis

Role of vascular endothelial growth factor in the pathogenesis of endometriosis

Immune and endocrine regulation in endometriosis: what we know

BDNF and TrKB expression levels in patients with endometriosis and their associations with dysmenorrhoea

Interactions between miRNAs and the Wnt/β-catenin signaling pathway in endometriosis

Current Status of Relationship Between Helper T Cell 17/regulatory T Cell Imbalance and Endometriosis